83_FR_1273 83 FR 1266 - National Institute on Drug Abuse; Notice of Meeting

83 FR 1266 - National Institute on Drug Abuse; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 7 (January 10, 2018)

Page Range1266-1267
FR Document2018-00218

Federal Register, Volume 83 Issue 7 (Wednesday, January 10, 2018) 
[Federal Register Volume 83, Number 7 (Wednesday, January 10, 2018)]
[Notices]
[Pages 1266-1267]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00218]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Council on Drug Abuse.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: February 6, 2018.
    Closed: 9:00 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Open: 10:30 a.m. to 4:30 p.m.
    Agenda: This portion of the meeting will be open to the public 
for announcements and reports of administrative, legislative, and 
program developments in the drug abuse field.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of 
Extramural Research, Office of the Director, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, NSC, Room 5274, MSC 
9591, Rockville, MD 20892, 301-443-6487, [email protected].

    Any member of the public interested in presenting oral comments to 
the committee may notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Only one representative of an organization may 
be allowed to present oral comments and if accepted by the committee, 
presentations may be limited to five minutes. Both printed and 
electronic copies are requested for the record. In addition, any 
interested person may file written comments with the committee by 
forwarding their statement to the Contact Person listed on this notice. 
The statement should include the name, address, telephone number and 
when applicable, the business or professional affiliation of the 
interested person.
    Information is also available on the Institute's/Center's home 
page: www.drugabuse.gov/NACDA/

[[Page 1267]]

NACDAHome.html, where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: January 4, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00218 Filed 1-9-18; 8:45 am]
 BILLING CODE 4140-01-P

1266 Federal Register / Vol. 83, No. 7 / Wednesday, January 10, 2018 / Notices Agenda: Discussion of program and issues. Name of Committee: National Institute of notify the Contact Person listed below Place: Nat. Inst. of Environmental Health Allergy and Infectious Diseases Special in advance of the meeting. Sciences, Building 101, Rodbell Auditorium, Emphasis Panel; ‘‘Induction of mucosal The meeting will be closed to the 111 T. W. Alexander Drive, Research immune responses for parenterally delivered public in accordance with the Triangle Park, NC 27709. vaccines’’. Date: February 5, 2018. provisions set forth in sections Contact Person: Gwen W Collman, Ph.D., Interim Director, Division of Extramural Time: 12:00 p.m. to 3:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Research & Training National Institutes of Agenda: To review and evaluate contract as amended. The grant applications Health, Nat. Inst. of Environmental Health proposals. and/or contract proposals and the Sciences, 615 Davis Dr., KEY615/3112, Place: National Institutes of Health, 5601 discussions could disclose confidential Research Triangle Park, NC 27709 (919) 541– Fishers Lane, Rockville, MD 20892 trade secrets or commercial property 4980, collman@niehs.nih.gov. (Telephone Conference Call). such as patentable material, and Contact Person: Eleazar Cohen, Ph.D., personal information concerning Any interested person may file written Scientific Review Officer, Scientific Review individuals associated with the grant comments with the committee by forwarding Program, Division of Extramural Activities, the statement to the Contact Person listed on Room 3G62A, National Institute of Health, applications and/or contract proposals, this notice. The statement should include the the disclosure of which would NIAID, 5601 Fishers Lane, MSC 9823, name, address, telephone number and when constitute a clearly unwarranted Bethesda, MD 20892–9823, (240) 669–5081, applicable, the business or professional invasion of personal privacy. ecohen@niaid.nih.gov. affiliation of the interested person. Information is also available on the Name of Committee: National Institute of Name of Committee: National Advisory Institute’s/Center’s home page: Allergy and Infectious Diseases Special Council on Drug Abuse. www.niehs.nih.gov/dert/c-agenda.htm, where Emphasis Panel; (PHS 2018–1) Small Date: February 6, 2018. an agenda and any additional information for Business Innovation Research (SBIR) Closed: 9:00 a.m. to 10:15 a.m. the meeting will be posted when available. Program Contract Solicitation (Topic 53) Agenda: To review and evaluate grant (N01). applications and/or proposals. (Catalogue of Federal Domestic Assistance Date: February 6, 2018. Place: National Institutes of Health, Program Nos. 93.115, Biometry and Risk Time: 1:00 p.m. to 5:00 p.m. Neuroscience Center, 6001 Executive Estimation—Health Risks from Agenda: To review and evaluate contract Boulevard, Rockville, MD 20852. Environmental Exposures; 93.142, NIEHS proposals. Open: 10:30 a.m. to 4:30 p.m. Hazardous Waste Worker Health and Safety Place: National Institutes of Health, 5601 Agenda: This portion of the meeting will Training; 93.143, NIEHS Superfund Fishers Lane, Rockville, MD 20892 be open to the public for announcements and Hazardous Substances—Basic Research and (Telephone Conference Call). reports of administrative, legislative, and Education; 93.894, Resources and Manpower Contact Person: Vasundhara Varthakavi, program developments in the drug abuse Development in the Environmental Health DVM, Ph.D., Scientific Review Officer, field. Sciences; 93.113, Biological Response to Scientific Review Program, Division of Place: National Institutes of Health, Environmental Health Hazards; 93.114, Extramural Activities, Room 3E70, National Neuroscience Center, 6001 Executive Applied Toxicological Research and Testing, Institutes of Health, NIAID, 5601 Fishers Boulevard, Rockville, MD 20852. National Institutes of Health, HHS) Lane, MSC 9823, Bethesda, MD 20892–9823, Contact Person: Susan R.B. Weiss, Ph.D., Dated: January 4, 2018. (240) 669–5020, varthakaviv@niaid.nih.gov. Director, Division of Extramural Research, Natasha M. Copeland, (Catalogue of Federal Domestic Assistance Office of the Director, National Institute on Program Analyst, Office of Federal Advisory Program Nos. 93.855, Allergy, Immunology, Drug Abuse, NIH, DHHS, 6001 Executive Committee Policy. and Transplantation Research; 93.856, Boulevard, NSC, Room 5274, MSC 9591, Microbiology and Infectious Diseases Rockville, MD 20892, 301–443–6487, [FR Doc. 2018–00220 Filed 1–9–18; 8:45 am] Research, National Institutes of Health, HHS) sweiss@nida.nih.gov. BILLING CODE 4140–01–P Dated: January 4, 2018. Any member of the public interested Natasha M. Copeland, in presenting oral comments to the DEPARTMENT OF HEALTH AND Program Analyst, Office of Federal Advisory committee may notify the Contact HUMAN SERVICES Committee Policy. Person listed on this notice at least 10 [FR Doc. 2018–00217 Filed 1–9–18; 8:45 am] days in advance of the meeting. National Institutes of Health BILLING CODE 4140–01–P Interested individuals and representatives of organizations may National Institute of Allergy and submit a letter of intent, a brief Infectious Diseases; Notice of Closed description of the organization DEPARTMENT OF HEALTH AND Meetings represented, and a short description of HUMAN SERVICES the oral presentation. Only one Pursuant to section 10(d) of the National Institutes of Health representative of an organization may be Federal Advisory Committee Act, as allowed to present oral comments and if amended, notice is hereby given of the National Institute on Drug Abuse; accepted by the committee, following meetings. Notice of Meeting presentations may be limited to five The meetings will be closed to the minutes. Both printed and electronic public in accordance with the Pursuant to section 10(d) of the copies are requested for the record. In provisions set forth in sections Federal Advisory Committee Act, as addition, any interested person may file 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., amended, notice is hereby given of a written comments with the committee as amended. The contract proposals and meeting of the National Advisory by forwarding their statement to the the discussions could disclose Council on Drug Abuse. Contact Person listed on this notice. The daltland on DSKBBV9HB2PROD with NOTICES confidential trade secrets or commercial The meeting will be open to the statement should include the name, property such as patentable material, public as indicated below, with address, telephone number and when and personal information concerning attendance limited to space available. applicable, the business or professional individuals associated with the contract Individuals who plan to attend and affiliation of the interested person. proposals, the disclosure of which need special assistance, such as sign Information is also available on the would constitute a clearly unwarranted language interpretation or other Institute’s/Center’s home page: invasion of personal privacy. reasonable accommodations, should www.drugabuse.gov/NACDA/ VerDate Sep<11>2014 18:23 Jan 09, 2018 Jkt 244001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\10JAN1.SGM 10JAN1

Federal Register / Vol. 83, No. 7 / Wednesday, January 10, 2018 / Notices 1267 NACDAHome.html, where an agenda Extramural Policy and Review, National should address one or more of the and any additional information for the Institute on Drug Abuse, National Institutes following four points: meeting will be posted when available. of Health, DHHS, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, (1) Evaluate whether the proposed (Catalogue of Federal Domestic Assistance 301–827–5820, hiromi.ono@nih.gov. collection of information is necessary Program Nos.: 93.279, Drug Abuse and for the proper performance of the (Catalogue of Federal Domestic Assistance Addiction Research Programs, National functions of the agency, including Program Nos.: 93.279, Drug Abuse and Institutes of Health, HHS) Addiction Research Programs, National whether the information will have Dated: January 4, 2018. Institutes of Health, HHS) practical utility; Natasha M. Copeland, Dated: January 4, 2018. (2) Evaluate the accuracy of the Program Analyst, Office of Federal Advisory Natasha M. Copeland, Committee Policy. agencies estimate of the burden of the Program Analyst, Office of Federal Advisory proposed collection of information, [FR Doc. 2018–00218 Filed 1–9–18; 8:45 am] Committee Policy. including the validity of the BILLING CODE 4140–01–P [FR Doc. 2018–00219 Filed 1–9–18; 8:45 am] methodology and assumptions used; BILLING CODE 4140–01–P (3) Enhance the quality, utility, and DEPARTMENT OF HEALTH AND clarity of the information to be HUMAN SERVICES collected; and DEPARTMENT OF HOMELAND National Institutes of Health SECURITY (4) Minimize the burden of the collection of information on those who National Institute on Drug Abuse; U.S. Immigration and Customs are to respond, including through the Notice of Closed Meetings Enforcement use of appropriate automated, electronic, mechanical, or other Pursuant to section 10(d) of the [OMB Control Number 1653–0038] technological collection techniques or Federal Advisory Committee Act, as Agency Information Collection other forms of information technology, amended, notice is hereby given of the Activities: Comment Request; e.g., permitting electronic submission of following meetings. The meetings will be closed to the Extension, With Changes, of an responses. public in accordance with the Information Collection Overview of This Information provisions set forth in sections AGENCY: U.S. Immigration and Customs Collection 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Enforcement, Department of Homeland as amended. The grant applications and Security. (1) Type of Information Collection: the discussions could disclose Extension, With Changes, of a Currently ACTION: 30-day notice. confidential trade secrets or commercial Approved Collection. property such as patentable material, The Department of Homeland (2) Title of the Form/Collection: and personal information concerning Security (DHS), U.S. Immigration and Student and Exchange Visitor individuals associated with the grant Customs Enforcement (USICE) is Information System (SEVIS). applications, the disclosure of which submitting the following information would constitute a clearly unwarranted collection request to the Office of (3) Agency form number, if any, and invasion of personal privacy. Management and Budget (OMB) for the applicable component of the review and clearance in accordance Department of Homeland Security Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, NIH with the Paperwork Reduction Act of sponsoring the collection: Forms I–17 Pathway to Independence Award (K99/R00). 1995. The information collection notice and I–20; U.S. Immigration and Customs Date: February 14, 2018. was previously published in the Federal Enforcement. Time: 1:00 p.m. to 4:00 p.m. Register on September 18, 2017, Vol. 82 (4) Affected public who will be asked Agenda: To review and evaluate grant FR 43565, allowing for a 60-day public or required to respond, as well as a brief applications. Place: National Institutes of Health, comment period. USICE did not receive abstract: Primary Non-profit institutions Neuroscience Center, 6001 Executive any comment relating to the 60-day and individuals or households. SEVIS is Boulevard, Rockville, MD 20852, (Telephone notice. The purpose of this notice is to an internet-based data-entry, collection Conference Call). allow an additional 30 days for public and reporting system. It collects Contact Person: Susan O. McGuire, Ph.D., comments. information on SEVP-certified schools Scientific Review Officer, Office of The burden estimates have been Extramural Policy and Review, National via the Form I–17, ‘‘Petition for revised since the 60-day notice to better Approval of School for Attendance by Institute on Drug Abuse, National Institutes reflect the number of potential of Health, DHHS, 6001 Executive Blvd., Nonimmigrant Student,’’ and collects Room 4245, Rockville, MD 20852, (301) 827– respondents to the collection. Written information on the F and M 5817, mcguireso@mail.nih.gov. comments and/or suggestions regarding nonimmigrant students that the SEVP- Name of Committee: National Institute on the items contained in this notice, certified schools admit into their Drug Abuse Special Emphasis Panel, especially regarding the estimated programs of study via the Forms I–20s: Pharmacogenomics of Anti-retroviral public burden and associated response ‘‘Certificate of Eligibility for Therapy in People Who Inject Drugs (R01). time, must be directed to the OMB Desk Nonimmigrant (F–1) Student Status— Date: February 15, 2018. Officer for U.S. Immigration and Time: 11:00 a.m. to 1:15 p.m. For Academic and Language Students’’ Customs Enforcement, Department of daltland on DSKBBV9HB2PROD with NOTICES Agenda: To review and evaluate grant and ‘‘Certificate of Eligibility for Homeland Security and sent via applications. Nonimmigrant (M–1) Student Status— electronic mail to dhsdeskofficer@ Place: National Institutes of Health, For Vocational Students’’. Neuroscience Center, 6001 Executive omb.eop.gov. All submissions received Boulevard, Rockville, MD 20852, (Telephone must include the agency name and the (5) An estimate of the total number of Conference Call). OMB Control Number 1653–0038. respondents and the amount of time Contact Person: Hiromi Ono, Ph.D., Written comments and suggestions estimated for an average respondent to Scientific Review Officer, Office of from the public and affected agencies respond: VerDate Sep<11>2014 18:23 Jan 09, 2018 Jkt 244001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\10JAN1.SGM 10JAN1


Document Created: 2018-10-26 09:34:23
Document Modified: 2018-10-26 09:34:23
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesFebruary 6, 2018.
FR Citation83 FR 1266 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR